Alibaba Health Information Technology Limited
ALBBY · OTC
9/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.26 | -0.68 | 0.00 |
| FCF Yield | 0.10% | 1.17% | 0.81% | 0.83% |
| EV / EBITDA | 542.36 | 96.90 | 140.83 | 76.82 |
| Quality | ||||
| ROIC | -6.14% | 3.78% | 1.89% | 4.77% |
| Gross Margin | 25.01% | 23.88% | 23.88% | 24.76% |
| Cash Conversion Ratio | 0.61 | 1.26 | 1.26 | 0.73 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.41% | 20.29% | 25.35% | 41.47% |
| Free Cash Flow Growth | 0.00% | 95.48% | -25.23% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -3.58 | -3.12 | -6.24 | -9.39 |
| Interest Coverage | 1,629.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.84 | 8.78 | 4.39 | 6.57 |
| Cash Conversion Cycle | -70.97 | 1.02 | -9.21 | 2.67 |